Dipeptide preparation Noopept prevents scopolamine-induced deficit of spatial memory in BALB/c mice

Bulletin of Experimental Biology and Medicine

Volumn 143, Issue 4, 2007, Pages 431-433

  Belnik, A P ^a   Ostrovskaya, Rita U ^a   Poletaeva, I I ^b  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Noopept; Proline containing peptides; Scopolamine; Spatial memory; Water maze

Indexed keywords

CHOLINE; DIPEPTIDE; NOOPEPT; NOOTROPIC AGENT; SCOPOLAMINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CHOLINERGIC RECEPTOR BLOCKING; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFICACY; LEARNING; LONG TERM MEMORY; MALE; MAZE TEST; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NONHUMAN; SPATIAL MEMORY;

ANIMALS; DIPEPTIDES; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED BALB C; NEUROPROTECTIVE AGENTS; NOOTROPIC AGENTS; SCOPOLAMINE; SPACE PERCEPTION;

MUS;

EID: 34648847037     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-007-0148-1     Document Type: Article

References (14)

1. T. A. Gudasheva, R. U. Ostrovskaya, S. S. Trofimov, et al., Khim. Farm. Zh., No. 11, 1322-1329 (1985).
2. I. G. Lil'p, F. Z. Bizikoeva, I. I. Poletaeva, et al., Genetika, 124, 666-668 (1997).
3. R. U. Ostrovskaya, Yu. V. Burov, N. I. Smol'nikova, et al., Farmakol. Toksikol., 4, 18-22 (1987).
4. R. U. Ostrovskaya, T. A. Gudasheva, T. A. Voronina, and S. B. Seredenin, Eksper. Klin. Farmakol., No. 5, 66-72 (2002).
5. R. U. Ostrovskaya, T. Kh. Mirzoev, F. A. Firova, et al., Ibid., 64, No. 2, 11-14 (2001).
6. R. T. Bartus, C. Flicker, R. L. Dean, et al., Prog. Brain Res., 70, 345-361 (1986).
7. G. J. Fricker, J. Peptide Sci., 2, No. 4, 195-211 (1996).
8. C. Giurgea, Actual Pharmacol. (Paris), 25, 115-156 (1972).
9. G. Gron, I. Brandenburg, A. P. Wunderlich, and M. W. Riepe, Neurobiol. Aging, 27, No. 1, 78-87 (2006).
10. T. A. Gudasheva, T. A. Voronina, R. U. Ostrovskaya, et al., Eur. J. Med. Chem., 31, 151-157 (1996).
11. D. K. Ingram and T. P. Corfman, Neurosci. Biobehav. Rev., 4, No. 4, 421-435 (1980).
12. R. Morris, J. Neurosci. Methods, 11, No. 1, 47-60 (1984).
13. R. U. Ostrovskaya, T. A. Gudasheva, S. Trofimov, et al., Biological Basis of Individual Sensitivity to Psychotropic Drugs, Eds. S. B. Seredenin et al., Edinburgh (1994), pp. 79-91.
14. A. Pelsman, C. Hoyo-Vadillo, T. A. Gudasheva, et al., Int. J. Dev. Neurosci., 21, No. 3, 117-124 (2003).